MANÜ Telehealth Review: Questions to Settle Before Enrolling

Before sharing a medical history or authorizing a recurring charge, a prospective MANÜ Telehealth patient has a more basic question to resolve: which description of the service applies? The homepage advertises provider and pharmacy coverage in all 50 states, while the privacy policy says the service is limited to Florida residents. That discrepancy matters more than an appealing daily price because it affects whether the enrollment process is appropriate to begin at all.

MANÜ does document a virtual weight-management offering built around compounded injectable semaglutide and tirzepatide. It also describes consultation, pharmacy fulfillment, supplies, shipping and ongoing support. This review examines public documentation consulted October 19, 2026, with an emphasis on questions patients can take back to the business. The aim is not to recommend a treatment, but to distinguish a documented offering from a complete, patient-specific explanation of costs, responsibilities and continuing care.

At a glance

Advertised medicines: MANÜ lists compounded injectable semaglutide and compounded injectable tirzepatide, not FDA-approved versions of those preparations.
Sources: [4] [6] [1]
Unresolved service area: The homepage advertises coverage in all 50 states, subject to address confirmation; the privacy policy restricts service to Florida residents.
Sources: [7] [10]
Partial pricing: Separate homepage blocks advertise GLP-1s from $4 per day and from $5 per day, without explaining the difference or establishing a complete billing-cycle price.
Sources: [7]
Clinical practice and platform: The intake identifies Ziggy Telehealth LLC as the healthcare provider; the legal center identifies Medoura, owned by CoFabri LLC, as the technology platform.
Sources: [3] [8]
Cancellation and refunds differ: General subscription cancellation is requested by email and normally takes effect at the billing cycle’s end. Partial periods generally are not refunded.
Sources: [11]

Can MANÜ serve you where you live?

The first practical step is to request a clear answer about location. MANÜ’s homepage says it currently has licensed providers and pharmacy coverage in all 50 U.S. states. It adds that coverage can change as the network and pharmacy licensing evolve, and directs applicants to enter an address during intake for confirmation. Standing alone, that describes nationwide availability with an individual address check—not an unconditional promise of access.

The privacy policy says something materially different: services are not currently available outside Florida, and non-Florida residents should not access or use them. It also says the business does not currently comply with state privacy and security laws outside Florida. The consulted documentation does not resolve which statement governs current enrollment. Someone outside Florida should seek clarification before entering sensitive health information rather than treating the homepage as the final answer.

The same policy excludes individuals located outside the United States and residents of other countries. Within the United States, ask for confirmation covering both the treating professional and the dispensing pharmacy for your address. Our guide to questions to settle before enrollment offers a broader framework, but MANÜ’s specific conflict deserves a direct response identifying which geographic terms apply to your application.

Sources: [7] [10]

Who is responsible for your clinical care?

MANÜ’s intake states that the platform supplies technology only and that healthcare services come from Ziggy Telehealth LLC. The legal center likewise identifies Ziggy as the healthcare practice shown to patients under the MANÜ Telehealth brand. Separately, it identifies Medoura as a technology platform owned and operated by CoFabri LLC, explicitly saying that Medoura is not a healthcare provider, medical practice, pharmacy, laboratory or emergency service.

The general terms complicate that otherwise useful division. They say MANÜ Telehealth is not a licensed medical provider and does not practice medicine, describing its role as connecting patients with independent licensed healthcare professionals. These statements may describe different entities or functions, but the public wording does not make their relationship consistently clear. Ask which legal entity accepts responsibility for your care and which name should appear on consent documents, clinical records and billing receipts.

There is also a staffing distinction worth clarifying. The semaglutide page says an approved applicant will receive a prescription from a board-certified physician. The team page lists Cristina, Nadja and Richard as nurse practitioners and Selvia as a family nurse practitioner. These are not interchangeable credentials. The consulted material does not independently verify licenses or certifications, provide full names or establish state assignments. Ask who would actually evaluate you and how to identify that professional.

Sources: [3] [8] [11] [5] [4]

What happens between the free assessment and a prescription?

The intake begins by requesting an email address and phone number so an applicant can start or resume an application. It advertises a free assessment taking less than five minutes, with nothing charged. That is a statement about completing the initial assessment, not a promise that a clinician will review it within five minutes. The homepage describes questions about health goals and medical history followed by review by healthcare professionals it describes as licensed.

The terms require users to be at least 18 and provide accurate, current and complete information. Both medication pages identify their intended adult population as people with a BMI of at least 30, or at least 27 with weight-related conditions. Those published thresholds are not a complete individualized eligibility assessment. The documentation does not establish required laboratory testing, laboratory charges, detailed admission exclusions or a separate process for patients already using a GLP-1 medication.

MANÜ says no in-person visits are required, but the consulted material does not fully define the consultation format. Its terms say a provider-patient relationship begins only when the professional explicitly accepts the patient, and a prescription is not guaranteed. Before proceeding, ask when that acceptance occurs, whether a live appointment is involved, what additional information may be requested and what payment consequences follow if the clinician declines to prescribe.

Sources: [3] [7] [4] [6] [11] [2]

Which medicine and formulation are actually being offered?

The core weight-loss products are explicitly labeled compounded semaglutide, injectable, and compounded tirzepatide, injectable. MANÜ’s semaglutide page says compounded medications are prepared by a licensed compounding pharmacy under a patient-specific prescription and are not FDA approved. The homepage says its compounded GLP-1s come exclusively from U.S. pharmacies and acknowledges that FDA has not evaluated those medications for safety, quality or efficacy. These disclosures are central to understanding the offer.

FDA recommends compounded drugs for patients whose medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality. Nonapproval alone does not establish clinical inequivalence, but neither does an ingredient name establish that a compounded preparation has the evidence or approval of a specific approved product. Ask the treating clinician to explain the proposed formulation and the individual reason for selecting it.

MANÜ also markets MIC Ultraburn, an injectable methionine, inositol and choline blend, as an add-on to GLP-1 treatment. Its claims about supporting metabolism and energy are provider marketing claims, not clinical findings established here. The wider catalog lists NAD+, sermorelin, glutathione and Bliss Tabs. Our guide to identifying the medicine behind an offer can help keep a core prescription, optional add-ons and their separate purposes from becoming one indistinct package.

Sources: [4] [6] [9] [7] [1]

What will you pay, and what does that payment include?

MANÜ’s homepage contains two different starting-price statements: GLP-1s “from $4/day” and “from $5/day,” both accompanied by free-shipping language. Neither block identifies the applicable medicine, supply quantity, billing interval or commitment behind that daily figure. The documentation does not explain the difference between the two amounts. They should therefore be read as partial advertising references, not converted into a presumed monthly bill or treated as a complete quote for either injectable.

There is more useful detail about package contents. The homepage FAQ says each medication package includes the online consultation, medication, supplies and shipping. MIC Ultraburn separately starts at $150, but its plan block does not specify a supply period or billing frequency. Ask for an itemized checkout summary showing the exact injectable formulation, presentation, quantity, first charge, subsequent charge and any optional add-on. A bundled description does not answer whether every possible laboratory or additional service charge is included.

Certain services use recurring billing, with the applicable fee and frequency disclosed at purchase. The terms also permit subscription price changes with advance notice and treat continued use after the effective date as acceptance. No complete semaglutide or tirzepatide cycle price, concrete prepayment plan or fully specified current discount was established in the consulted material. These questions beyond the monthly price are especially relevant when an advertisement quotes a daily starting amount.

MANÜ payment statements and the questions they leave open
Published statement	What it establishes	What to ask
GLP-1s from $4/day	A starting-price advertisement with free shipping	Which medicine, presentation, supply and billing interval qualify?
GLP-1s from $5/day	A second, different starting-price advertisement	Why does this differ from the $4 statement?
MIC Ultraburn starting at $150	A starting price for the injectable add-on	What quantity and supply period does it cover?
Consultation, medication, supplies and shipping included	The stated contents of a medication package	Which tests or additional services, if any, cost extra?
Recurring fee and frequency stated at purchase	Some services renew automatically	What are the first charge, next charge and renewal date?

Sources: [7] [9] [11]

Who fills the prescription and handles delivery problems?

MANÜ explicitly says it is not an internet pharmacy and does not dispense, ship or distribute medication from its facility or website. Its homepage says prescribed medications are dispensed exclusively through a U.S. 503A pharmacy. The privacy policy names Boudreaux, Shields Pharmacy and Hallandale as pharmacies that prepare and ship prescribed medication. That identifies possible participants, but it does not establish which pharmacy would fulfill an individual order; their licenses were not independently verified for this review.

The advertised process is direct-to-home delivery from a U.S. pharmacy, with free shipping and discreet packaging. The consulted documentation does not establish a clinical-review deadline, pharmacy preparation time, dispatch schedule or arrival window. It also does not set out a complete cold-chain policy or replacement terms for damaged clinical shipments. Ask for the assigned pharmacy’s name and contact information before fulfillment, along with the route for resolving a delayed, damaged or temperature-concerning delivery.

FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. That guidance is more specific than simply asking whether a parcel shipped on time. MANÜ’s legal center directs shipping and fulfillment questions to the responsible practice, merchant, pharmacy or other provider identified in the workflow or receipt. Request those details in a form you can retain rather than relying only on the brand’s homepage.

Sources: [7] [10] [8] [1]

What does ongoing support actually mean?

MANÜ’s institutional page advertises continuous support, regular check-ins, treatment-plan adjustments as needed, progress tracking and 24/7 patient support. Those are meaningful categories of service, but the documentation does not establish a specific follow-up cadence or response-time commitment. Ask whether scheduled follow-ups are automatic, who reviews concerns between appointments, how refill requests are assessed and which channel reaches clinical staff rather than administrative support. Availability to submit a message is not the same as immediate clinical review.

The legal center expressly warns that messages, forms, intake submissions and refill requests may not be reviewed immediately. It says the platform is not for emergencies, directs emergencies to 911 or the nearest emergency department, and identifies 988 for a U.S. suicide, self-harm or mental-health crisis. These limits qualify the 24/7 advertising. A useful enrollment answer would distinguish routine support hours, clinical escalation and emergency boundaries without suggesting that the platform replaces emergency care.

Follow-up should also be distinguishable from automatic payment renewal. NIDDK describes medication decisions as involving benefits, side effects, health conditions, other medicines and costs, with follow-up addressing tolerance and response. For MANÜ, ask how those discussions are organized and documented. FDA has reported errors measuring or administering compounded medication, some involving hospitalization; preparation-specific instructions should be clarified with the prescriber or pharmacist, not calculated from a review. No patient dosing instructions are established here.

Sources: [5] [8] [2] [1]

How do you stop future charges or request records?

The general subscription terms say patients may cancel by contacting info@manutelehealth.com. Cancellation normally takes effect at the end of the current billing cycle unless otherwise specified, and partial billing periods generally are not refunded unless required by applicable law. Cancellation therefore should not be understood as a promise to reverse an existing charge. Before enrolling, establish which subscription you are buying, when the next charge occurs and how cancellation confirmation will be delivered.

The broader sales policy says sales are final, subject to specified exceptions, and generally rules out refunds once services have been rendered or medication dispensed. If MANÜ cancels an already-paid order, the terms promise a full refund to the original payment method; they do not establish a bank-arrival deadline. A separate rule requires at least 48 hours’ notice before a nutrition-store subscription renewal, warning that later requests may not prevent that cycle’s charge and shipment. That deadline is not automatically the clinical subscription rule.

The nutrition-store provisions take priority only for their own transactions. Keep that distinction visible if buying more than one service, and use these renewal questions to organize a written record of each charge and cancellation route. For clinical continuity, the privacy policy says patients can request an electronic or paper record copy or summary, usually within 30 days, with a possible reasonable cost-based fee. Ask who holds the record and where the request should be sent.

Sources: [11] [8] [10]

Questions & answers

Does MANÜ’s free assessment guarantee a prescription?

No. The intake advertises a free assessment taking less than five minutes with nothing charged, but that does not establish the clinical-review timeline or guarantee acceptance. The terms reserve prescribing decisions to the treating professional and say the provider-patient relationship requires explicit acceptance. Ask what happens next, when payment is requested and what charges could apply if medication is not prescribed.

Sources: [3] [11]

Can someone outside Florida enroll?

The consulted documentation does not provide a consistent answer. The homepage advertises all-state provider and pharmacy coverage subject to address confirmation, while the privacy policy says services are limited to Florida and tells non-Florida residents not to use them. Seek clarification before submitting health information. Neither ignoring the restriction nor assuming the service definitely lacks outside-Florida capacity resolves the documentary conflict.

Sources: [7] [10]

Is the advertised $4 or $5 daily amount the full price?

It is not a complete quote in the consulted material. The homepage displays both starting amounts without identifying the qualifying product, supply or commitment, or explaining their difference. Its FAQ does say medication packages include consultation, medication, supplies and shipping. Obtain the exact first payment, renewal payment and billing interval rather than treating either daily amount as an established monthly price.

Sources: [7] [11]

Does MANÜ accept insurance or HSA/FSA payments?

The consulted public documentation does not establish insurance acceptance, medication coverage, prior-authorization assistance or HSA/FSA payment availability. Generic privacy references involving insurers do not answer those questions. Ask MANÜ about its payment arrangements and ask your health plan separately about the specific service and medicine. NIDDK notes that coverage of weight-management medication varies; consultation coverage and medication coverage are separate matters.

Sources: [10] [2]

Does 24/7 support mean a clinician will answer immediately?

No immediate-response commitment was established. MANÜ advertises 24/7 patient support, regular follow-ups and progress tracking, but its legal center warns that messages and refill requests may not be reviewed immediately. Ask which channel handles clinical concerns, who monitors it and what response window applies. The platform expressly is not an emergency service, so its support advertising should not be read as emergency coverage.

Sources: [5] [8]

Does canceling MANÜ mean I receive a refund?

Not generally. The general terms separate stopping a subscription from refunding paid services: cancellation normally takes effect at cycle end, with no partial-period refund unless required by law. Sales generally are final after services are rendered or medication dispensed. MANÜ-initiated cancellation of a paid order carries a full-refund promise. The separate 48-hour renewal-notice rule applies to nutrition-store subscriptions, not automatically to clinical care.

Sources: [11]

Our assessment

MANÜ documents an identifiable virtual-care offering: two compounded injectable weight-loss medicines, an initial assessment, bundled consultation and fulfillment, and advertised ongoing support. It also names the clinical practice, technology platform and possible pharmacy participants. Those details give patients useful starting points. The unresolved geography conflict, inconsistent clinical-role descriptions and incomplete daily-price advertisements nevertheless leave consequential enrollment questions unanswered. Before authorizing payment, obtain a written explanation of state availability, the responsible clinician and practice, the exact prescription and pharmacy, the full billing cycle and the applicable cancellation terms. Clear answers would make the offer easier to evaluate; the public documentation alone does not settle them.

Visit MANÜ Telehealth’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

MANÜ Telehealth Review: Questions to Settle Before Enrolling

At a glance

01Can MANÜ serve you where you live?

02Who is responsible for your clinical care?

03What happens between the free assessment and a prescription?

04Which medicine and formulation are actually being offered?

05What will you pay, and what does that payment include?

06Who fills the prescription and handles delivery problems?

07What does ongoing support actually mean?

08How do you stop future charges or request records?